UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases — San Antonio, Texas

UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Alzheimer Disease, Cognitive Impairment, Mild Cognitive Impairment.

Sponsors: Cognito Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases?

UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases conducted?

UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases has 2 clinical trials on record, with 2 currently active. Their work covers Alzheimer Disease, Cognitive Impairment, Mild Cognitive Impairment.

Is UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases accredited by Crixeo Health?

UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.